MRSA: An Evolving Pathogen

Disease-a-Month

Volumn 54, Issue 12, 2008, Pages 751-755

  Corriere, Mark D ^a   Decker, Catherine F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; PENICILLIN RESISTANCE; REVIEW; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASE CONTROL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 55249115318     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.09.007     Document Type: Review

References (20)

1. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298 (2007) 1763-1771
2. Flynn N., and Cohen S.H. The continuing saga of MRSA. J Infect Dis 197 (2008) 1217-1219
3. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococci: position statement from the joint SHEA and APIC Task Force. Inf Control Hosp Epidemiol 28 (2007) 249-260
4. Diekema D.J., and Climo M. Preventing MRSA infections. J Am Med Assoc 299 (2008) 1190-1192
5. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 (2001) 178-182
6. Stewart G.T., and Holt R.J. Evolution of natural resistance to the new penicillins. Br Med J 1 5326 (1963) 308-311
7. Benner E.J., and Kayser F.H. Growing clinical significance of methicillin resistant Staphylococcus aureus. Lancet 2 (1968) 741
8. Saravolatx L.D., Markowitz N., Arking L., et al. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community acquired outbreak. Ann Intern Med 96 1 (1982) 11-16
9. Brumfitt W., and Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 320 (1989) 1188-1196
10. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
11. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community acquired methicillin resistant Staphylococcus aureus in children with no identified predisposing risk. J Am Med Assoc 279 (1998) 593-598
12. Centers for Disease Control. Four pediatric deaths from community acquired methicillin resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. J Am Med Assoc 282 (1999) 1122-1125
13. Enright M.C., Robinson D.A., Randle G., et al. The evolutionary history of methicillin resistant Staphylococcal aureus (MRSA). Proc Natl Acad Sci U S A 99 (2002) 7687
14. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
15. Noskin G.A., Krishnadasan A., Gorwitz R.J., et al. The burden of Staphylococcus aureus infections on hospitals in the United States. Arch Intern Med 16 (2005) 1756-1761
16. Rubin R.J., Harrington C.A., Poon A., et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 5 (1999) 9-17
17. Engeman J.J., Carmilli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36 (2003) 592-599
18. Pfaller M.A., Jones R.N., Doern G.V., et al. Survey of blood stream infections attributable to gram positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn Microbiol Infect Dis 33 (1999) 283-297
19. Lodise T.P., and McKinnon P.S. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 52 (2005) 113-122
20. Cosgrove S.E., Sakoulus G., Parencevich E.N., et al. Comparison of mortality associated with methicillin resistant and methicillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59